Resistance trends and risk factors of extended spectrum β-lactamases in Escherichia coli infections in Aleppo, Syria

Multidrug-Resistant Urinary Tract Isolates of <i>Escherichia coli:</i> Prevalence and Patient Demographics in the United States in 2000

Daniel F. Sahm, Clyde Thornsberry, David C. Mayfield et al. · Antimicrobial Agents and Chemotherapy · 2001 · 297 citations · Full text

Escherichia Coli, Antibiotic Resistance, United States +17

Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit Admission

Anthony D. Harris, Jessina C. McGregor, Judith A. Johnson et al. · Emerging infectious diseases · 2007 · 174 citations · Full text

Pathogenic Microbiology, Klebsiella Pneumoniae, Bacterial Pathogens +16

Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran, Iran

Nasim Kashef, Gholamreza Esmaeeli Djavid, Sahba Shahbazi · The Journal of Infection in Developing Countries · 2010 · 160 citations · Full text

Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania

Sabrina J. Moyo, Said Aboud, Mabula Kasubi et al. · BMC Research Notes · 2010 · 142 citations · Full text

Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings

Abiola Senok, Husam S. Khanfar, Khalid Mubarak Bindayna et al. · The Journal of Infection in Developing Countries · 2009 · 139 citations · Full text